Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 41.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 160.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 701
  • Market Cap: £15.67m
  • Beta: 0.01

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.

1 Day Chart (23-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -211.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.1 n/a
Pr/Book 2.9  
Latest F'cast
Revenue 10.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AREC Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.70 (3.51) (17.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.16 (6.95) (27.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 2.40 (10.54) (32.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 4.57 (8.90) (0.28)p n/a n/a n/a n/a 0.0%
31-Dec-24 5.05 (10.62) (0.31)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AREC Company Announcements

Director/PDMR Dealing 21-May-2025 07:00 RNS
Arecor Partnership with Skye Bioscience 19-May-2025 07:00 RNS
Director Dealing 14-May-2025 14:37 RNS

Latest AREC Director Deals

Traded Action Notifier PriceAmountValue
19-May-25 Buy Sarah Jennifer Howell 46.97p 21,077 £9,899.87
19-May-25 Buy Andrew Richards 46.97p 31,750 £14,912.98
13-May-25 Buy Andrew Richards 41.25p 35,000 £14,437.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

AREC Market Data

Currency UK Pounds
Share Price 41.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 160.00
52 Week Low 38.00
Volume 701
Shares Issued 37.76m
Market Cap £15.67m
Beta 0.01

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Trend
92.98% below the market average92.98% below the market average92.98% below the market average92.98% below the market average92.98% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average
Income Not Available
Growth
41.76% above the market average41.76% above the market average41.76% above the market average41.76% above the market average41.76% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

AREC Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
11:42 698 @ 42.94p
10:23 3 @ 43.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page